BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24839986)

  • 1. Restoration of fibroblast growth factor receptor 2IIIb enhances the chemosensitivity of human prostate cancer cells.
    Shoji K; Teishima J; Hayashi T; Ohara S; Mckeehan WL; Matsubara A
    Oncol Rep; 2014 Jul; 32(1):65-70. PubMed ID: 24839986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of fibroblast growth factor receptor2 suppresses growth and tumorigenicity of malignant human prostate carcinoma PC-3 cells.
    Yasumoto H; Matsubara A; Mutaguchi K; Usui T; McKeehan WL
    Prostate; 2004 Nov; 61(3):236-42. PubMed ID: 15368475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of FGF receptor type 2 enhances radiosensitivity of hormone-refractory human prostate carcinoma PC-3 cells.
    Matsubara A; Teishima J; Mirkhat S; Yasumoto H; Mochizuki H; Seki M; Mutaguchi K; Mckeehan WL; Usui T
    Anticancer Res; 2008; 28(4B):2141-6. PubMed ID: 18751387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of IGFBP-rP1 increases radiosensitivity and chemosensitivity in hormone-refractory human prostate cancer.
    Seki M; Teishima J; Mochizuki H; Mutaguchi K; Yasumoto H; Oka K; Nagamatsu H; Shoji K; Matsubara A
    Hiroshima J Med Sci; 2013 Mar; 62(1):13-9. PubMed ID: 23600329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2.
    Matsubara A; Kan M; Feng S; McKeehan WL
    Cancer Res; 1998 Apr; 58(7):1509-14. PubMed ID: 9537256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer.
    Morgan C; Lewis PD; Jones RM; Bertelli G; Thomas GA; Leonard RC
    Acta Oncol; 2007; 46(5):669-77. PubMed ID: 17562444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer.
    Mutaguchi K; Yasumoto H; Mita K; Matsubara A; Shiina H; Igawa M; Dahiya R; Usui T
    Cancer Res; 2003 Nov; 63(22):7717-23. PubMed ID: 14633696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1).
    Hour TC; Chung SD; Kang WY; Lin YC; Chuang SJ; Huang AM; Wu WJ; Huang SP; Huang CY; Pu YS
    Arch Toxicol; 2015 Apr; 89(4):591-605. PubMed ID: 24888374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells.
    O'Connor K; Gill C; Tacke M; Rehmann FJ; Strohfeldt K; Sweeney N; Fitzpatrick JM; Watson RW
    Apoptosis; 2006 Jul; 11(7):1205-14. PubMed ID: 16699961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
    Wang P; Liu B; Luo JD; Zhang ZG; Ma Q; Chen ZD
    Asian J Androl; 2007 May; 9(3):353-60. PubMed ID: 17486276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer.
    Yu L; Wu X; Chen M; Huang H; He Y; Wang H; Li D; Du Z; Zhang K; Goodin S; Zheng X
    Int J Med Sci; 2017; 14(4):356-366. PubMed ID: 28553168
    [No Abstract]   [Full Text] [Related]  

  • 13. The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer.
    Dyshlovoy SA; Menchinskaya ES; Venz S; Rast S; Amann K; Hauschild J; Otte K; Kalinin VI; Silchenko AS; Avilov SA; Alsdorf W; Madanchi R; Bokemeyer C; Schumacher U; Walther R; Aminin DL; Fedorov SN; Shubina LK; Stonik VA; Balabanov S; Honecker F; von Amsberg G
    Int J Cancer; 2016 May; 138(10):2450-65. PubMed ID: 26695519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.
    Feng S; Wang F; Matsubara A; Kan M; McKeehan WL
    Cancer Res; 1997 Dec; 57(23):5369-78. PubMed ID: 9393762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense suppression of proline-directed protein kinase FA enhances chemosensitivity in human prostate cancer cells.
    Yang CC; Hsu CP; Yang SD
    Clin Cancer Res; 2000 Mar; 6(3):1024-30. PubMed ID: 10741730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of JNK-1 by small interfering RNA induces apoptotic signaling in PC-3 prostate cancer cells.
    Parra E
    Int J Mol Med; 2012 Oct; 30(4):923-30. PubMed ID: 22766602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel.
    Yang Z; Chen JS; Wen JK; Gao HT; Zheng B; Qu CB; Liu KL; Zhang ML; Gu JF; Li JD; Zhang YP; Li W; Wang XL; Zhang Y
    J Exp Clin Cancer Res; 2017 Dec; 36(1):178. PubMed ID: 29216925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.